Pet Instrumentation for Quantitative Tracing of Radiopharmaceuticals

2021 ◽  
pp. 69-92
Author(s):  
Iwao Kanno
Keyword(s):  
Author(s):  
C. W. Lerche ◽  
J. Felder ◽  
C.-H. Choi ◽  
N. J. Shah
Keyword(s):  

2004 ◽  
Vol 42 (6) ◽  
pp. 1003-1016 ◽  
Author(s):  
Suleman Surti ◽  
Joel S. Karp ◽  
Paul E. Kinahan
Keyword(s):  

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Abass Alavi ◽  
Thomas J. Werner ◽  
Ewa Ł. Stępień ◽  
Pawel Moskal

Abstract Positron emission tomography (PET) imaging is the most quantitative modality for assessing disease activity at the molecular and cellular levels, and therefore, it allows monitoring its course and determining the efficacy of various therapeutic interventions. In this scientific communication, we describe the unparalleled and revolutionary impact of PET imaging on research and day to day practice of medicine. We emphasize the critical importance of the development and synthesis of novel radiotracers (starting from the enormous impact of F-Fluorodeouxyglucose (FDG) introduced by investigators at the University of Pennsylvania (PENN)) and PET instrumentation. These innovations have led to the total-body PET systems enabling dynamic and parametric molecular imaging of all organs in the body simultaneously. We also present our perspectives for future development of molecular imaging by multiphoton PET systems that will enable users to extract substantial information (owing to the evolving role of positronium imaging) about the related molecular and biological bases of various disorders, which are unachievable by the current PET imaging techniques.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Yaser H. Gholami ◽  
Hushan Yuan ◽  
Moses Q. Wilks ◽  
Lee Josephson ◽  
Georges El Fakhri ◽  
...  

AbstractIn positron emission tomography (PET), the finite range over which positrons travel before annihilating with an electron places a fundamental physical limit on the spatial resolution of PET images. After annihilation, the photon pair detected by the PET instrumentation is emitted from a location that is different from the positron-emitting source, resulting in image blurring. Here, we report on the localization of positron range, and hence annihilation quanta, by strong nanoscale magnetization of superparamagnetic iron oxide nanoparticles (SPIONs) in PET-MRI. We found that positron annihilations localize within a region of interest by up to 60% more when SPIONs are present (with [Fe] = 3 mM) compared to when they are not. The resulting full width at half maximum of the PET scans showed the spatial resolution improved by up to $$\approx$$ ≈  30%. We also found evidence suggesting that the radiolabeled SPIONs produced up to a six-fold increase in ortho-positronium. These results may also have implications for emerging cancer theranostic strategies, where charged particles are used as therapeutic as well as diagnostic agents and improved dose localization within a tumor is a determinant of better treatment outcomes.


Author(s):  
Nikant Sabharwal ◽  
Chee Yee Loong ◽  
Andrew Kelion

Introduction to cardiac positron emission tomography (PET) 212PET instrumentation (1) 214PET instrumentation (2) 216Radiopharmaceuticals for cardiac PET (1) 218Radiopharmaceuticals for cardiac PET (2) 220Interpretation and clinical significance of cardiac PET studies 222As in single photon emission computed tomography (SPECT), positron emission tomography (PET) involves the injection of a radiopharmaceutical, the physiological properties of which determine its distribution within the patient. The labelling radionuclide then allows this distribution to be imaged. In contrast to SPECT, the positron-emitting radionuclides used in PET produce pairs of high energy 511keV ...


Sign in / Sign up

Export Citation Format

Share Document